Merz Pharmaceuticals, LLC

NC · United States · Reporting entity ID 100000005377

Total reported 2019–2025

$9.04M

#524 of 2,960 reporting companies — 0% of all reported industry payments

$4.35M in general payments across 31,816 records, plus $4.68M in research funding across 567 records.

How it breaks down

General payments $4,353,742

Research funding $4,684,985

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.